FDA scientists opposed the Trump administration’s effort to ease peptides access
By MATTHEW PERRONE WASHINGTON (AP) — A plan to give Americans easier access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. was opposed by most Food and Drug Administration scientific staff members, who had limited input…